{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:38:52Z","timestamp":1767166732008,"version":"build-2238731810"},"reference-count":30,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1050,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1742-1241.2012.03001.x","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T06:57:53Z","timestamp":1350370673000},"page":"1033-1041","source":"Crossref","is-referenced-by-count":6,"title":["Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings"],"prefix":"10.1155","volume":"66","author":[{"given":"V.","family":"P\u012br\u0101gs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"El Damassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ra\u010dick\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Martinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Giaconia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On Behalf of the B001 Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1742-1241.2009.02332.x","article-title":"Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes","volume":"64","author":"Barnett","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pcd.2009.08.007","article-title":"Hypoglycaemia: an overview","volume":"3","author":"Graveling","year":"2009","journal-title":"Prim Care Diabetes"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/14656566.4.7.1141","article-title":"Insulin analogues and other developments in insulin therapy for diabetes","volume":"4","author":"McAulay","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJMra040832","article-title":"Insulin analogues","volume":"352","author":"Hirsch","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejim.2006.09.006","article-title":"Basal insulin or premix analogue therapy in type 2 diabetes patients","volume":"18","author":"Raskin","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa075392","article-title":"Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes","volume":"357","author":"Holman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2105\/AJPH.85.2.156","article-title":"The tribulations of trials - intervention in communities","volume":"85","author":"Susser","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/dmrr.929","article-title":"Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin","volume":"25","author":"Chan","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2012.03001.x-BIB13|cit13","first-page":"S11","article-title":"Standards of medical care in diabetes - 2012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0029-1212102","article-title":"Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy","volume":"107","author":"G\u00fcrlek","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/diacare.26.4.1176","article-title":"Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use","volume":"26","author":"Leese","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1046\/j.1464-5491.2003.01072.x","article-title":"Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness","volume":"20","author":"Henderson","year":"2003","journal-title":"Diabet Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.2005.01501.x","article-title":"Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated \/type 2 diabetes: a population-based study","volume":"22","author":"Donnelly","year":"2005","journal-title":"Diabet Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.2337\/diacare.28.12.2948","article-title":"Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities","volume":"28","author":"Zammitt","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.161.13.1653","article-title":"Hypoglycemia in patients with type 2 diabetes mellitus","volume":"161","author":"Miller","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB20|cit20","first-page":"10","article-title":"Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes","volume":"19","author":"Murata","year":"2005","journal-title":"J Diabetes Complications"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-2003-42728","article-title":"Clinical characterisation of severe hypoglycaemia - a prospective population-based study","volume":"111","author":"Holstein","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pcd.2011.02.003","article-title":"Initiation of biphasic insulin aspart 30\/70 in subjects with type 2 diabetes mellitus in a largely primary care-based setting in Sweden","volume":"5","author":"Berntorp","year":"2011","journal-title":"Prim Care Diabetes"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2012.03001.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ijo.0802175","article-title":"Reducing hypoglycaemia with insulin analogues","volume":"26","author":"Heller","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB24|cit24","first-page":"9","article-title":"The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study","volume":"5","author":"Goodall","year":"2009","journal-title":"BMC Endocr Disord"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1464-5491.2007.02279.x","article-title":"Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK","volume":"24","author":"Rubino","year":"2007","journal-title":"Diabet Med"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/SMJ.0b013e318182d8a2","article-title":"Consequences of delaying progression to optimal therapy in patients with type 2 diabetes not achieving glycemic goals","volume":"102","author":"Hsu","year":"2009","journal-title":"South Med J"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1185\/03007990902739669","article-title":"Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study","volume":"25","author":"Jones","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-010-1702-3","article-title":"Is the ADA\/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis","volume":"53","author":"Schernthaner","year":"2010","journal-title":"Diabetologia"},{"key":"10.1111\/j.1742-1241.2012.03001.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00125-009-1468-7","article-title":"Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses","volume":"52","author":"Lasserson","year":"2009","journal-title":"Diabetologia"}],"updated-by":[{"DOI":"10.1111\/ijcp.12201","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T00:00:00Z","timestamp":1368662400000}}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2012.03001.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2012.03001.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:03:34Z","timestamp":1643331814000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2012.03001.x"}},"subtitle":["Low risk of severe hypoglycaemia with premixed insulin analogues"],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2012.03001.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}